Product Information

CARBAMAZEPINE ER 200 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.3776 per EA under NDC 50742025801. Its NADAC has been published 150 times since Oct 11, 2023.

FDA first approved this application on Dec 2, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARBAMAZEPINE ER 200 MG TABLET

carbamazepine
$0.3776per EA

Strength

200 mg/1

NDC

50742025801

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARBAMAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA216404

FDA Approved

12/2/2022

TE Code

AB

On Market Since

8/1/2023

Pharmacological Classes

Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Mood Stabilizer

Price Statistics

The NADAC for CARBAMAZEPINE ER 200 MG TABLET has been published 150 times since Oct 11, 2023, and over the history we have for it it has declined 29.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3776 per EA
All-time high$0.6386 (Mar 13, 2024)
All-time low$0.2489 (Nov 20, 2024)
52-week high$0.4219
52-week low$0.3488
Median price$0.4126
Average price$0.4359
Largest weekly change+79.9% (Jun 19, 2024)
Weeks tracked150
Tracking sinceOct 11, 2023

Price History

1W

+2.5%

1M

+2.5%

3M

-1.0%

6M

-3.4%

1Y

-10.5%

3Y

N/A

5Y

N/A

All

-29.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CARBAMAZEPINE ER 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE ER 200 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.3776 per EA (NDC 50742025801), effective Aug 19, 2026.

How has the price of CARBAMAZEPINE ER 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARBAMAZEPINE ER 200 MG TABLET has declined 29.0%. It has been tracked across 150 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE ER 200 MG TABLET?

Since Oct 11, 2023, the NADAC for CARBAMAZEPINE ER 200 MG TABLET has ranged from a low of $0.2489 (Nov 20, 2024) to a high of $0.6386 (Mar 13, 2024), with a median of $0.4126 per EA.

Are there cheaper alternatives to CARBAMAZEPINE ER 200 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARBAMAZEPINE ER 200 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CARBAMAZEPINE ER 200 MG TABLET?

CARBAMAZEPINE ER 200 MG TABLET (NDC 50742025801) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.